Øystein Rekdal

Directeur Général chez LYTIX BIOPHARMA

Health Technology

Consumer Services

Postes actifs de Øystein Rekdal

Sociétés	Poste	Début	Fin
LYTIX BIOPHARMA	Directeur Général	11/09/2019	-
	Fondateur	01/01/2003	-
	Directeur/Membre du Conseil	26/04/2010	21/04/2011
	Directeur Technique/Scientifique/R&D	-	11/09/2019
	Corporate Officer/Principal	01/01/2003	-
University of Tromso	Corporate Officer/Principal	-	-

Sociétés	Poste	Début	Fin
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.	Directeur/Membre du Conseil	15/04/2010	-

University of Tromso

Doctorate Degree

Internationale

Norvège

Opérationnelle

Director/Board Member	2
Corporate Officer/Principal	2
Chief Executive Officer	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
LYTIX BIOPHARMA	Health Technology

Entreprise privées	1
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.	Health Technology

Entreprise privées

Health Technology